Bladder Cancer
📧 Sign up to get email alerts when something new happens for Bladder Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-08-07Clinical Trial Update: Physical Activity, Kinesiophobia, and Stoma Compliance in Urostomy Patients
A clinical trial update noting ongoing enrollment by invitation for a study on physical activity, kinesiophobia, and stoma compliance in uro…
-
CLINICAL_TRIALS trial_result · 2024-08-06Clinical Trial Update: Measuring and Improving the Safety of Test Result Follow-Up [NA]
This clinical trial update reports the completion and posting of results for a study assessing methods to measure and improve safety in the …
-
CLINICAL_TRIALS research · 2024-07-31Clinical Trial Update: Comparison of Two Approaches of Quadratus Lumborum Block for Post-operative Analgesia in Radical Cystectomy [NA]
This clinical trial compares two approaches to quadratus lumborum block for postoperative analgesia in patients undergoing radical cystectom…
-
CLINICAL_TRIALS research · 2024-07-30Clinical Trial Update: Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer [Phase 2]
Phase 2 trial exploring bladder-preserving therapy with sacituzumab govitecan plus zimberelimab for muscle-invasive bladder cancer; the stud…
-
CLINICAL_TRIALS trial_result · 2024-07-25Clinical Trial Update: Study of Genistein in Reducing Side Effects of Superficial Bladder Cancer Treatment [Phase 2]
Phase 2 trial results evaluating genistein to reduce side effects of superficial bladder cancer treatment have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-23Clinical Trial Update: My Pathway: A Study Evaluating Herceptin/Perjeta, Tarceva, Zelboraf/Cotellic, Erivedge, Alecensa, and Tecentriq Treatment Targeted Against Certain Molecular Alterations in Participants With Advanced Solid Tumors [Phase 2]
Phase 2 trial update from Genentech evaluating combinations of Herceptin, Perjeta, Tarceva, Zelboraf, Cotellic, Erivedge, Alecensa, and Tece…
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Radiotherapy for BCG-unresponsive Non-muscle-invasive Carcinoma in Situ (CIS) Bladder Cancer [Phase 2]
This document reports a Phase 2 clinical trial evaluating radiotherapy for BCG-unresponsive non-muscle-invasive bladder cancer in situ (CIS)…
-
CLINICAL_TRIALS research · 2024-07-19Clinical Trial Update: SArcopenia, Mobility, PHYsical Activity and Post-operative Risk of Bladder Carcinoma in the Elderly [NA]
Clinical trial update on sarcopenia, mobility, physical activity, and postoperative risk in elderly bladder cancer patients.
-
CLINICAL_TRIALS research · 2024-07-18Clinical Trial Update: Reconstitution of a Human Immune System in a Patient Derived Xenograft (PDX) Model of Genitourinary (GU) Cancers
Clinical trial update on reconstituting a human immune system in a patient-derived xenograft model of genitourinary cancers; the study statu…
-
CLINICAL_TRIALS research · 2024-07-15Clinical Trial Update: Influence of Preoperative Immunomodulation by Oral Impact on Postoperative Complications Following Cystectomies & Nephrectomies [NA]
This clinical trial is evaluating whether preoperative oral immunomodulation can influence postoperative complications after cystectomy and …
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria
This clinical trial evaluates a urine DNA methylation test for detecting urothelial carcinoma in patients with hematuria.
-
CLINICAL_TRIALS trial_result · 2024-07-03Clinical Trial Update: Atezolizumab and CYT107 in Treating Participants With Locally Advanced, Inoperable, or Metastatic Urothelial Carcinoma [Phase 2]
Phase 2 trial results evaluate the combination of atezolizumab and CYT107 in participants with locally advanced, inoperable, or metastatic u…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: Gemcitabine, Cisplatin, Plus Nivolumab in Patients With Muscle-invasive Bladder Cancer With Selective Bladder Sparing [Phase 2]
Phase 2 trial evaluating the combination of gemcitabine, cisplatin, and nivolumab in muscle-invasive bladder cancer with selective bladder-s…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: A Study of Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer [Phase 3]
Phase 3 trial comparing Nivolumab plus Bempegaldesleukin versus Nivolumab alone and standard of care in cisplatin-ineligible muscle-invasive…
-
CLINICAL_TRIALS trial_result · 2024-06-27Clinical Trial Update: PatientCareAnywhere Internet-Based Software in Improving Communication and Education in Patients With Cancer and Their Healthcare Providers [NA]
A completed clinical trial evaluating the PatientCareAnywhere internet-based software, intended to improve communication and education for c…
-
CLINICAL_TRIALS trial_result · 2024-06-25Clinical Trial Update: Pembrolizumab in Treating Patients With Bladder Cancer Undergoing Radical Cystectomy [Phase 2]
A Phase 2 clinical trial evaluating pembrolizumab in bladder cancer patients undergoing radical cystectomy has completed and posted results …
-
CLINICAL_TRIALS research · 2024-06-25Clinical Trial Update: AI Detection of Bladder Tumors Under Endoscopy
This clinical trial investigates an AI-based system to detect bladder tumors during endoscopy. Recruitment is ongoing at Peking Union Medica…
-
CLINICAL_TRIALS research · 2024-06-20Clinical Trial Update: Urine DNA Methylation Detection for Hematuria Evaluation
ClinicalTrials.gov entry for a study evaluating urine DNA methylation as a noninvasive test to evaluate hematuria and screen for urothelial …
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Safety, Dose Tolerance, Pharmacokinetics, Pharmacodynamics of CPX-POM in Patients With Newly Diagnosed or Recurrent Bladder Tumors [Phase 2]
Phase 2 study evaluating safety, dose tolerance, pharmacokinetics, and pharmacodynamics of CPX-POM in patients with bladder tumors; results …
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: Study of ADCT-301 in Patients With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial update for ADCT-301 (camidanlumab tesirine) in selected advanced solid tumors; the study has been terminated and results have …
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: A Phase 3 Study of UGN-102 for Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer [Phase 3]
A Phase 3 study of UGN-102 for low-grade intermediate-risk non-muscle invasive bladder cancer was terminated, with results posted on 2024-06…
-
CLINICAL_TRIALS trial_result · 2024-06-06Clinical Trial Update: Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay
The AnchorDx UriFind bladder cancer validation trial (NCT05643690) is currently suspended during the urine sample collection phase.
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Impacts and Testing of the "Multi-domains Active-living Program" in Operable Non-Muscle Invasive Bladder Cancer Patients [NA]
This document reports a clinical trial update on the Multi-domains Active-living Program for operable non-muscle invasive bladder cancer pat…
-
CLINICAL_TRIALS research · 2024-06-05Clinical Trial Update: Elastographic Analysis of Urothelial Bladder Tumours
This clinical trial investigates elastographic analysis of urothelial bladder tumors and includes elastographic measurement and intravesical…
-
CLINICAL_TRIALS trial_result · 2024-05-31Clinical Trial Update: Neoadjuvant Atezolizumab in Localized Bladder Cancer [Phase 2]
Phase 2 neoadjuvant study of atezolizumab in localized bladder cancer has completed, with results posted on May 31, 2024.